Apellis Pharmaceuticals shares owned by Citigroup
Quarter-by-quarter ownership of Apellis Pharmaceuticals shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $6.5k | 6.0k | 1.09 |
| 2024-06-30 | $7.7k | 6.0k | 1.28 |
| 2024-03-31 | $9.8k | 6.0k | 1.63 |
| 2023-12-31 | $821k | 504k | 1.63 |
| 2023-09-30 | $623k | 504k | 1.24 |
| 2023-03-31 | $203k | 109k | 1.86 |
| 2022-12-31 | $4.6k | 3.0k | 1.53 |
| 2022-09-30 | $292k | 150k | 1.95 |
| 2021-03-31 | $22k | 16k | 1.38 |
| 2020-12-31 | $25k | 15k | 1.67 |